Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

RELIZON PHARMACEUTICALS products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore pharmaceutical manufacturer with a cGMP-oriented facility and a portfolio covering solid, liquid and other pharmaceutical dosage forms.

RELIZON PHARMACEUTICALS products in Pakistan

RELIZON PHARMACEUTICALS has 63 medicine presentations registered in Pakistan under 26 brands, covering 27 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Malazon (Artemether + Lumefantrine, Artemether), Azith (Azithromycin), Gabazon (Pregabalin) and Ciprorel (Ciprofloxacin). 63 products have an official DRAP price on MedInfoBase. See all 26 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date12 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Relizon Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 118, Sundar Industrial Estate, Raiwind Road, Lahore 54000, Pakistan · 54000
Phone
+92 42 35297119; +92 301 4724862
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000875 Relizon Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000875 63 linked products · source seen 11 Nov 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx69public portfolio records represented
REG54unique registrations represented
IDX63indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+6registry-only registrations
VER6registry-verified exact registrations
PKR63current validated price records
G27generic molecules in indexed catalogue
DF4dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage91%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage97%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixRELIZON PHARMACEUTICALSShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/relizon-pharmaceuticalsGenerated 11 Nov 2026Anti-infectives42 · 67%CNS & mental health6 · 10%Gastrointestinal & hepatology5 · 8%Oncology & immunology4 · 6%Respiratory & allergy3 · 5%Pain & musculoskeletal3 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioRELIZON PHARMACEUTICALSDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/relizon-pharmaceuticalsGenerated 11 Nov 202663presentationsTablet37 · 59%Capsule14 · 22%Suspension9 · 14%Injection3 · 5%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionRELIZON PHARMACEUTICALSCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/relizon-pharmaceuticalsGenerated 11 Nov 202661comparable productsBelow peer median60 · 98%Near peer median0 · 0%Above peer median1 · 2%Company median price position-18.4%Lowest-price equivalents16Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsRELIZON PHARMACEUTICALSCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/relizon-pharmaceuticalsGenerated 11 Nov 2026Macter International Limited23 shared85% overlapNeutro Pharma (Pvt.) Ltd.,23 shared85% overlapNabiqasim Industries (Pvt) Ltd.,21 shared78% overlapBosch Pharmaceuticals (Pvt) Ltd.21 shared78% overlapSAMI Pharmaceuticals Pvt. Ltd.21 shared78% overlapHamaz Pharmaceuticals (Pvt) Ltd.21 shared78% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives42 products · 67%
CNS & mental health6 products · 10%
Gastrointestinal & hepatology5 products · 8%
Oncology & immunology4 products · 6%
Respiratory & allergy3 products · 5%
Pain & musculoskeletal3 products · 5%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antimalarials10 products · 16%
Macrolide antibacterials9 products · 14%
Fluoroquinolone antibacterials7 products · 11%
Antiepileptics5 products · 8%
Antivirals5 products · 8%
Antineoplastic medicines4 products · 6%
Proton pump inhibitors4 products · 6%
Analgesics / NSAIDs3 products · 5%
Formulation footprint

Dosage forms

Tablet37 products
Capsule14 products
Suspension9 products
Injection3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AzithAzithromycin 5presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #2 GabazonPregabalin 5presentations 150 mg, 300 mg, 75 mg · Capsule #3 CiprorelCiprofloxacin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #4 KlamzonClarithromycin 4presentations 125 mg/5 mL, 250 mg, 250 MG/5 mL, 500 mg · Suspension, Tablet #5 MalazonArtemether + Lumefantrine 4presentations 15 mg/5 mL + 90 mg/5 mL, 40 mg + 240 mg · Suspension, Tablet #6 RemezonOmeprazole 4presentations 20 mg, 40 mg · Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where RELIZON PHARMACEUTICALS is priced against the market

61 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Macter International Limited243 products · 91 generics 23shared generics Neutro Pharma (Pvt.) Ltd.,209 products · 96 generics 23shared generics Nabiqasim Industries (Pvt) Ltd.,361 products · 117 generics 21shared generics

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers48Distinct registrations among indexed, published, presentation-validated products only
Verified price observations63
Products with a verified price63
Products with multiple price observations0
Source records with multiple versions62
Latest portfolio source check12 Oct 2026
Latest effective price date12 Aug 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

54 unique registration(s) · 63 indexed presentation(s) · 6 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Anukast Montelukast 10 mg Tablet 14's 100709 PKR 519.64 PKR 37.12/tablet 🔒 Pharma Pro
Astron Anastrozole 1 mg Tablet 30's 093731 PKR 8,647.68 PKR 288.26/tablet 🔒 Pharma Pro
Astron Anastrozole 1 mg Tablet 10's 093731 PKR 3,133.22 PKR 313.32/tablet 🔒 Pharma Pro
Azith Azithromycin 250 mg Capsule 6's 090603 PKR 256.47 PKR 42.75/capsule 🔒 Pharma Pro
Azith Azithromycin 250 mg Capsule 10's 090603 PKR 427.45 PKR 42.75/capsule 🔒 Pharma Pro
Azith Azithromycin 200 mg/5 mL Suspension 15ml 090617 PKR 276.58 PKR 18.44/mL 🔒 Pharma Pro
Azith Azithromycin 250 mg Tablet 6's 114073 PKR 239.17 PKR 39.86/tablet 🔒 Pharma Pro
Azith Azithromycin 500 mg Tablet 6's 114074 PKR 438.48 PKR 73.08/tablet 🔒 Pharma Pro
Bufizon Ibuprofen 200 mg Tablet 100's 114075 PKR 387.16 PKR 3.87/tablet 🔒 Pharma Pro
Bufizon Ibuprofen 400 mg Tablet 100's 117688 PKR 313.19 PKR 3.13/tablet 🔒 Pharma Pro
Cetrizon Cetirizine 10 mg Tablet 100's 114077 PKR 650.44 PKR 6.50/tablet 🔒 Pharma Pro
Cetrizon Cetirizine 10 mg Tablet 10's 114077 PKR 58.92 PKR 5.89/tablet 🔒 Pharma Pro
Ciprorel Ciprofloxacin 250 mg Tablet 10's 091558 PKR 217.92 PKR 21.79/tablet 🔒 Pharma Pro
Ciprorel Ciprofloxacin 500 mg Tablet 10's 091559 PKR 360.40 PKR 36.04/tablet 🔒 Pharma Pro
Ciprorel Ciprofloxacin 125 mg/5 mL Suspension 60ml 096712 PKR 143.50 PKR 2.39/mL 🔒 Pharma Pro
Ciprorel Ciprofloxacin 250 mg/5 mL Suspension 60ml 098393 PKR 238.43 PKR 3.97/mL 🔒 Pharma Pro
Ferva 500mg/10ml InjectionRegistry verified Iron as Ferric Carboxymaltose — — — 136774Official source ↗ No indexed price — —
Fuzon Fluconazole 150 mg Capsule 1's 090604 PKR 231.33 PKR 231.33/capsule 🔒 Pharma Pro
Fuzon Fluconazole 200 mg Capsule 4's 090605 PKR 804.61 PKR 201.15/capsule 🔒 Pharma Pro
Fuzon Fluconazole 50 mg/5 mL Suspension 35ml 090618 PKR 352.02 PKR 10.06/mL 🔒 Pharma Pro
Gabazon Pregabalin 150 mg Capsule 14's 090608 PKR 600.54 PKR 42.90/capsule 🔒 Pharma Pro
Gabazon Pregabalin 150 mg Capsule 10's 090608 PKR 429.17 PKR 42.92/capsule 🔒 Pharma Pro
Gabazon Pregabalin 300 mg Capsule 14's 090610 PKR 1,001.39 PKR 71.53/capsule No comparator
Gabazon Pregabalin 75 mg Capsule 14's 090612 PKR 333.80 PKR 23.84/capsule 🔒 Pharma Pro
Gabazon Pregabalin 75 mg Capsule 10's 090612 PKR 238.43 PKR 23.84/capsule 🔒 Pharma Pro
Klamzon Clarithromycin 250 mg Tablet 10's 090590 PKR 314.64 PKR 31.46/tablet 🔒 Pharma Pro
Klamzon Clarithromycin 500 mg Tablet 10's 090591 PKR 670.51 PKR 67.05/tablet 🔒 Pharma Pro
Klamzon Clarithromycin 125 mg/5 mL Suspension 60ml 090628 PKR 373.81 PKR 6.23/mL 🔒 Pharma Pro
Klamzon Clarithromycin 250 MG/5 mL Suspension 60ml 090629 PKR 482.45 PKR 8.04/mL 🔒 Pharma Pro
Letrazo Letrozole 2.5 mg Tablet 30's 090602 PKR 7,866.00 PKR 262.20/tablet 🔒 Pharma Pro
Letrazo Letrozole 2.5 mg Tablet 10's 090602 PKR 2,622.00 PKR 262.20/tablet 🔒 Pharma Pro
Linezon Linezolid 400 mg Tablet 12's 090593 PKR 2,447.35 PKR 203.95/tablet 🔒 Pharma Pro
Linezon Linezolid 600 mg Tablet 12's 090594 PKR 4,284.55 PKR 357.05/tablet 🔒 Pharma Pro
Linezon Linezolid 100 mg/5 mL Suspension 60ml 096660 PKR 521.56 PKR 8.69/mL 🔒 Pharma Pro
Malazon Artemether 20 mg Tablet 16's 090598 PKR 536.41 PKR 33.53/tablet 🔒 Pharma Pro
Malazon Artemether + Lumefantrine 40 mg + 240 mg Tablet 10's 090599 PKR 406.41 PKR 40.64/tablet 🔒 Pharma Pro
Malazon Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 090599 PKR 373.90 PKR 46.74/tablet 🔒 Pharma Pro
Malazon Artemether 80 mg Tablet 6's 090600 PKR 497.52 PKR 82.92/tablet 🔒 Pharma Pro
Malazon Artemether 80 mg Tablet 4's 090600 PKR 288.42 PKR 72.11/tablet 🔒 Pharma Pro
Malazon Artemether + Lumefantrine 15 mg/5 mL + 90 mg/5 mL Suspension 60ml 090619 PKR 248.09 PKR 4.13/mL 🔒 Pharma Pro
Malazon Artemether + Lumefantrine 15 mg/5 mL + 90 mg/5 mL Suspension 30ml 090619 PKR 135.69 PKR 4.52/mL 🔒 Pharma Pro
Moxizon Moxifloxacin 400 mg Tablet 5's 090592 PKR 796.23 PKR 159.25/tablet 🔒 Pharma Pro
Nidaz Metronidazole 400 mg Tablet 200's 117552 PKR 478.34 PKR 2.39/tablet 🔒 Pharma Pro
Nidaz Metronidazole 400 mg Tablet 100's 117552 PKR 239.17 PKR 2.39/tablet 🔒 Pharma Pro
Nidaz Metronidazole 400 mg Tablet 20's 117552 PKR 47.83 PKR 2.39/tablet 🔒 Pharma Pro
Ondixa Ondansetron 8 mg/4 mL Injection 5'sx4ml 136775 PKR 2,585.00 PKR 129.25/mL 🔒 Pharma Pro
Oseltazon Oseltamivir 75 mg Capsule 10's 104600 PKR 1,033.69 PKR 103.37/capsule 🔒 Pharma Pro
Papranto 40mg TabletRegistry verified Pantoprazole (as sodium sesquihydrate) — — — 108118Official source ↗ No indexed price — —
Quizon Chloroquine 250 mg Tablet 500's 106185 PKR 615.47 PKR 1.23/tablet 🔒 Pharma Pro
Rel-hcq Hydroxychloroquine 200 mg Tablet 50's 106184 PKR 589.95 PKR 11.80/tablet 🔒 Pharma Pro
A to Z

All 26 RELIZON PHARMACEUTICALS brands in Pakistan

  • Anukast Montelukast · 10 mg tablet
  • Astron Anastrozole · 1 mg tablet
  • Azith Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
  • Bufizon Ibuprofen · 200 mg tablet, 400 mg tablet
  • Cetrizon Cetirizine · 10 mg tablet
  • Ciprorel Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
  • Fuzon Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg/5 mL suspension
  • Gabazon Pregabalin · 150 mg capsule, 300 mg capsule, 75 mg capsule
  • Klamzon Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 250 MG/5 mL suspension
  • Letrazo Letrozole · 2.5 mg tablet
  • Linezon Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
  • Malazon Artemether + Lumefantrine, Artemether · 15 mg/5 mL + 90 mg/5 mL suspension, 20 mg tablet, 40 mg + 240 mg tablet
  • Moxizon Moxifloxacin · 400 mg tablet
  • Nidaz Metronidazole · 400 mg tablet
  • Ondixa Ondansetron · 8 mg/4 mL injection
  • Oseltazon Oseltamivir · 75 mg capsule
  • Quizon Chloroquine · 250 mg tablet
  • Rel-hcq Hydroxychloroquine · 200 mg tablet
  • Relmol Paracetamol · 500 mg tablet
  • Relrit Lopinavir + Ritonavir · 50 mg + 200 mg tablet
  • Relvir Tenofovir disoproxil · 300 mg tablet
  • Relvo Levofloxacin · 250 mg tablet, 500 mg tablet
  • Relxetine Paroxetine · 12.5 mg tablet
  • Remezon Omeprazole · 20 mg capsule, 40 mg capsule
  • Tecazon Entecavir · 0.5 mg tablet
  • Xontrix Ceftriaxone · 250 mg injection, 500 mg injection
Questions

RELIZON PHARMACEUTICALS: common questions

How many products does RELIZON PHARMACEUTICALS have in Pakistan?

RELIZON PHARMACEUTICALS has 63 registered medicine presentations in Pakistan, sold under 26 brands and covering 27 generic medicines.

What are the main brands of RELIZON PHARMACEUTICALS?

By number of registered strengths and packs, its largest brands are Malazon (Artemether + Lumefantrine, Artemether), Azith (Azithromycin), Gabazon (Pregabalin), Ciprorel (Ciprofloxacin) and Klamzon (Clarithromycin). This is not a sales ranking.

Which therapy areas does RELIZON PHARMACEUTICALS cover?

The most products are in Anti-infectives (42), CNS & mental health (6), Gastrointestinal & hepatology (5), Oncology & immunology (4) and Respiratory & allergy (3).

Where can I see RELIZON PHARMACEUTICALS medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). RELIZON PHARMACEUTICALS — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/relizon-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9